# Immunogenicity and safety of human papillomavirus‐16/18 AS04‐adjuvanted cervical cancer vaccine in healthy Indian women

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/immunogenicity-and-safety-of-human-papillomavirus-16-18-as04-adjuvanted-cervical/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Neerja Bhatla,Vanita Suri,Partha Basu,Surendra S. Shastri,Sanjoy Datta,Dan Bi,Dominique Descamps,Hans L. Bock,the Indian HPV Vaccine Study Group |
| Citations | 52 |
| DOI | 10.1111/j.1447-0756.2009.01167.x |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2087404749 |
| PMID | 20178538 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Dan Bi](https://scholariq.org/researchers/dan-bi/)

## Paper primary topic

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)

## Paper topics

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Pharmacology and Nanomedicine Research](https://scholariq.org/topics/pharmacology-and-nanomedicine-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.